Every week, a founder asks me: should we raise on a SAFE or a convertible note? After 25 years of closing these deals, here’s my honest answer: it depends. But the reasons why might surprise you.
Most guides on this topic are written by platforms trying to sell you cap table software. I’m writing this as the lawyer who sits across the table from your investors and negotiates these terms. The perspective is different.
For background on early-stage financing instruments generally, see my complete guide to convertible notes.
What Each One Is
A SAFE — Simple Agreement for Future Equity — is not a loan. It has no interest rate, no maturity date, and no obligation to repay. It is a contract that gives the investor the right to receive equity in a future priced round, subject to a valuation cap and/or discount. Y Combinator created the SAFE in 2013, and it has become the dominant instrument for pre-seed and seed-stage fundraising.
A convertible note is an actual debt instrument. The company borrows money from the investor, promises to pay it back with interest, and sets a maturity date by which the note must be repaid or converted. If a qualifying financing occurs before maturity, the note converts into equity at a discount or subject to a cap.
Same goal — bridge to a priced round — but fundamentally different legal structures with different consequences.
Head-to-Head Comparison
| Feature | SAFE | Convertible Note |
|---|---|---|
| Legal structure | Convertible security / contract for future equity | Debt |
| Interest | None | 2–8% annually |
| Maturity date | None | 12–24 months |
| Legal cost | $0–2K | $3K–10K+ |
| Balance sheet | Off-balance-sheet | Shows as liability |
| Conversion trigger | Any equity financing | Qualified financing or at maturity |
| Investor protections | Fewer | Interest, maturity pressure, security interests |
| Speed to close | Days | 1–4 weeks |
| Market prevalence | ~90% pre-seed/seed | Bridge rounds, institutional investors |
When SAFEs Win
For most pre-seed and seed rounds in 2026, the post-money SAFE is the right choice. It is fast, cheap, and well-understood by the angel and early-stage investor community. If you are raising $500K to $2M from angels or small funds, a SAFE gets the money in the door with minimal friction.
The post-money SAFE (as opposed to the older pre-money version) is now the standard. The critical difference: the post-money SAFE’s valuation cap includes the SAFE itself in the capitalization, so you know exactly how much dilution you’re taking. The pre-money version did not, which led to cap table surprises. Use the post-money version.
SAFEs also win when you are raising in tranches. Because there is no maturity date, you can keep a SAFE round open and add investors over weeks or months without triggering default provisions or amendment requirements.
There is also a structural reason SAFEs are friendlier to founders that most guides skip entirely: the qualified financing requirement in convertible notes. Most notes only convert automatically when the company raises a minimum amount — say, $1 million or $2 million — in a preferred stock financing. If your next round comes in below that threshold, the note doesn’t convert. It just keeps sitting on the balance sheet as debt, accruing interest, ticking toward its maturity date. Founders who raise a smaller-than-expected priced round can find themselves in the worst of both worlds: new equity investors on the cap table and unconverted debt holders still holding leverage. SAFEs don’t have this problem — a SAFE converts on any equity financing with no minimum threshold. That’s a meaningful protection for founders navigating uncertain fundraising environments.
When Convertible Notes Win
Convertible notes are not dead. They are the better choice in several specific situations:
Bridge rounds between priced rounds. If you closed a Series A and need $500K to get to Series B, a convertible note makes more sense. Your Series A investors expect debt protections, and the maturity date creates healthy pressure to close the next round.
Institutional investors who require debt. Some funds have mandates that limit equity investments at certain stages. A convertible note satisfies their compliance requirements while still providing conversion economics.
International investors. SAFEs are an American invention. International investors — particularly in Europe and Asia — are often more comfortable with convertible notes, which have direct analogs in their legal systems.
When you want the maturity date pressure. This is counterintuitive, but some founders benefit from having a deadline. A 24-month maturity date forces you to either raise a priced round or have a hard conversation with your note holders. Sometimes that pressure is productive.
The Traps Founders Miss
The maturity date bomb. If your convertible note matures and you have not raised a priced round, you owe the money back. Most startups cannot repay a $500K note on demand. This creates leverage for investors and stress for founders. Always negotiate an automatic extension or conversion-at-maturity provision.
SAFE stacking complexity. If you raise $500K on a $5M cap SAFE, then another $300K on a $7M cap SAFE, then another $200K on a $10M cap SAFE, your cap table becomes a puzzle. Each SAFE converts at a different price, and the dilution math is not intuitive. I have seen founders shocked at how much of their company they gave away across multiple SAFE rounds.
Post-money vs. pre-money SAFE. This is the single most common mistake. A $10M post-money cap is NOT the same as a $10M pre-money cap. The post-money cap includes the SAFE itself in the denominator, resulting in more dilution. Know which one you are signing.
Pro rata rights. Many SAFEs include pro rata rights that give investors the right to maintain their percentage ownership in future rounds. This is standard, but founders sometimes don’t realize they have committed to setting aside allocation for all their SAFE investors in the Series A.
Tax Considerations Most Guides Ignore
This is where my perspective as a tax attorney differs from the cap table software companies writing competing guides.
Convertible notes accrue interest. That interest is taxable income to the investor, even though they never receive cash. And when the note converts, the accrued interest converts into additional shares — creating a small but real dilution event that founders rarely model.
SAFEs have their own tax complexity. The IRS has not issued definitive guidance on the tax treatment of SAFEs. There is a risk that SAFEs could be treated as prepaid forward contracts, creating phantom income issues for investors. Section 305 of the Internal Revenue Code could treat the discount or cap as a deemed distribution, which has tax consequences for both the company and the investor.
For founders, the most important tax question is whether the eventual conversion preserves QSBS eligibility under Section 1202. If your C-corp stock qualifies as QSBS, a properly structured conversion from either a SAFE or note can maintain that status. But get it wrong and you could lose the Section 1202 exclusion — potentially costing millions at exit.
Similarly, if employees or founders receive restricted stock in connection with a conversion, the 83(b) election deadline starts ticking. Miss the 30-day window and the tax consequences can be severe.
Washington State Angle
For Washington founders, neither SAFEs nor convertible notes themselves trigger the new 9.9% income tax (ESSB 6346). The tax applies to income, and neither instrument creates income at issuance. But the eventual conversion and exit will — which is why structuring for QSBS eligibility from the start matters. A $15 million QSBS exit is tax-free. A $15 million non-QSBS exit faces roughly $5 million in combined federal and Washington tax. The financing instrument you choose today affects that outcome.
The Bottom Line
For most early-stage startups raising their first outside capital in 2026, use a post-money SAFE. It is faster, cheaper, and the market standard. Your angels expect it.
Use a convertible note when you have a specific reason — bridge financing, institutional investor requirements, or international investors. Do not use a note just because it feels more “serious.”
Either way, do not treat this as a commodity document you download and sign. The terms in your SAFE or note — the cap, the discount, the pro rata rights, the conversion mechanics — will affect your cap table, your taxes, and your exit for years to come. Get them right from the start.
Have questions about structuring your round? Book a 20-minute intro call.
Want founder-focused legal and tax insights in your inbox? Subscribe to the newsletter — it’s free.
For more on protecting your exit from tax, see the Complete Guide to QSBS & Section 1202.
